Home » Topics » BioWorld Science

BioWorld Science
RSS

Separating the good, the bad and the indifferent in neurodegeneration

July 3, 2018

From Adam's rib to Miss Piggy's jaw

July 3, 2018

Imfinzi approved in Japan for the treatment of unresectable stage III NSCLC

July 2, 2018

LEO Pharma initiates phase I study of LEO-138559

July 2, 2018

JCR initiates phase II study of JR-141 as treatment of Hunter syndrome in Brazil

July 2, 2018

EMA committee recommends marketing authorization for Veyvondi

July 2, 2018

IMpassion130 study of Tecentriq plus Abraxane meets primary endpoint

July 2, 2018

Lynparza receives Japanese approval for BRCA-mutated metastatic breast cancer

July 2, 2018

CHMP adopts positive opinion for Yescarta

July 2, 2018

Phase II results presented from pivotal CAPTIVATE trial of ibrutinib plus venetoclax

July 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...